Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 17, 242-244
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Recent advances in the diagnosis and management of tuberculous meningitisCurrent Opinion in Infectious Diseases, 2017
- MDR-TB and XDR-TB Surveillance Highlights Need for Rapid Detection of Drug-Resistance in Mycobacterium Tuberculosis InfectionsInternational Journal of Current Microbiology and Applied Sciences, 2017
- Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistanceThe International Journal of Tuberculosis and Lung Disease, 2015
- Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated FactorsPLOS ONE, 2015
- Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007Emerging Infectious Diseases, 2014
- Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2011
- MDR-TB and XDR-TB: drug resistance and treatment outcomes: Table 1—European Respiratory Journal, 2009
- Rapid Detection of Mycobacterium tuberculosis Resistance to Second-Line Drugs by Use of the Manual Mycobacterium Growth Indicator Tube SystemJournal of Clinical Microbiology, 2008
- Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South AfricaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatmentBritish Medical Bulletin, 2005